Wegovy pill Canada and Foundayo: the GLP-1 pills in Canada

“Wegovy pill Canada” and “orforglipron Canada” are two of the fastest-growing medication searches in the country. Both tablets are sold in the United States. Here is where each one stands in Canada, and which GLP-1 tablet a Canadian pharmacy can dispense today.

Short answer: at the time this page was last reviewed (10 November 2026), the only GLP-1 tablet authorized by Health Canada was Rybelsus (oral semaglutide). Foundayo (orforglipron) and the Wegovy pill had no Drug Identification Number (DIN), so no pharmacy in Canada, ours included, can dispense them yet.

GLP-1 pills in Canada at a glance

TabletMoleculeMakerUnited StatesCanada
Rybelsussemaglutide (oral)Novo NordiskSoldAuthorized and marketed: 1.5, 3, 4, 7, 9 and 14 mg tablets
Wegovy pillsemaglutide 25 mg (oral)Novo NordiskFDA approval 22 December 2025Not authorized; no DIN
FoundayoorforglipronEli LillyFDA approval 1 April 2026Under Health Canada review; no DIN

Source: Health Canada Drug Product Database, checked 10 November 2026. A product is only authorized in Canada once it has a DIN in that database.

Wegovy pill Canada: is it available?

Not yet. The Wegovy sold in Canada is the once-weekly Wegovy pen. Novo Nordisk’s once-daily Wegovy tablet (semaglutide 25 mg) was approved in the United States in December 2025, but no Wegovy tablet appears in Health Canada’s database. Every Wegovy DIN in Canada is a pre-filled pen.

If you are looking for semaglutide as a tablet, the one authorized in Canada is Rybelsus. It is a different product from the US Wegovy pill, with its own strengths, and a prescriber decides whether it suits you.

Orforglipron Canada: where the Foundayo review stands

Orforglipron is Eli Lilly’s once-daily GLP-1 tablet. Unlike semaglutide, it is a small molecule rather than a peptide. The US Food and Drug Administration approved it as Foundayo on 1 April 2026.

In Canada, Eli Lilly’s submission has been reported as under Health Canada review since January 2026. Health Canada does not publish target decision dates for individual drugs. Until it issues a Notice of Compliance and a DIN, orforglipron cannot be prescribed in the normal way or dispensed by a Canadian pharmacy. We will add Foundayo to our GLP-1 price list on the day it is authorized.

Then what is being sold online as Foundayo or the Wegovy pill?

Websites that offer these tablets to Canadians are either shipping a product that has not been reviewed for the Canadian market, or something that is not what the label says. Neither has passed through a Canadian pharmacy, and no Canadian pharmacist has checked it against your other medications. If a site offers you a GLP-1 tablet without a Canadian prescription and a Canadian DIN, treat that as a warning sign.

What you can do today

Questions about GLP-1 pills in Canada

Is the Wegovy pill available in Canada?

No. At the last review of this page, Health Canada had not authorized a Wegovy tablet. Wegovy is available in Canada as a weekly pen.

Is orforglipron approved in Canada?

Not yet. Orforglipron (Foundayo) is approved in the United States and has been reported as under Health Canada review since January 2026. It has no Canadian DIN.

When will Foundayo be available in Canada?

Nobody outside Health Canada and Eli Lilly can give a date. Once Health Canada authorizes it, it will appear in the Drug Product Database with a DIN, and pharmacies can then dispense it with a prescription.

Is there a GLP-1 pill in Canada?

Yes, one: Rybelsus, the oral form of semaglutide, made by Novo Nordisk. It needs a prescription.

Can I bring Foundayo or the Wegovy pill back from the United States?

Talk to a pharmacist before you do. A product without a Canadian DIN has not been reviewed by Health Canada, and a Canadian pharmacy cannot refill it or support you with it.

Reviewed by our pharmacist-in-charge on 10 November 2026. This page is general information, not medical advice. See also peptides in Canada.